Table 3. Donor/recipient chimerism... | American Society of Hematology

Table 3.

Donor/recipient chimerism status of antigen-specific TCLs

	3-5 mo after CBT					12-15 mo after CBT
Patient no.	PBMC	HCMV-TCL	CA-TCL	PBMC	HCMV-TCL	CA-TCL
CBT-sib
6^*	MC 15% R	MC 59% R	MC 49% R	MC 10% R	MC 46% R	MC 34% R
7†	MC 20% R	MC 28% R	ND	MC 10% R	MC 33% R	MC 19% R
8†	MC 8% R	CC	MC 10% R	MC 8% R	CC	MC 7% R
9^*	MC 27% R	MC 89% R	ND	MC 18% R	MC 95% R	ND
10†	MC 25% R	MC 50% R	ND	MC 35% R	MC 70% R	ND
11†	CC	CC	CC	CC	CC	CC
CBT-ud
14†	CC	CC	CC	CC	CC	CC
16†	CC	CC	CC	CC	CC	CC

	3-5 mo after CBT					12-15 mo after CBT
Patient no.	PBMC	HCMV-TCL	CA-TCL	PBMC	HCMV-TCL	CA-TCL
CBT-sib
6^*	MC 15% R	MC 59% R	MC 49% R	MC 10% R	MC 46% R	MC 34% R
7†	MC 20% R	MC 28% R	ND	MC 10% R	MC 33% R	MC 19% R
8†	MC 8% R	CC	MC 10% R	MC 8% R	CC	MC 7% R
9^*	MC 27% R	MC 89% R	ND	MC 18% R	MC 95% R	ND
10†	MC 25% R	MC 50% R	ND	MC 35% R	MC 70% R	ND
11†	CC	CC	CC	CC	CC	CC
CBT-ud
14†	CC	CC	CC	CC	CC	CC
16†	CC	CC	CC	CC	CC	CC

MC indicates mixed donor/recipient (D/R) chimerism; ND, not done; and CC, complete donor chimerism.

T-cell populations obtained from pooled positive wells of LDA.

TCLs obtained after short-term culture.